ARCHIVES

Pilot Study Tests Novel “Metronomic” Delivery

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | December 30, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

Feinstein Reintroduces New National Cancer Act

June 13, 2003

NCI contract Awards; RFPs Available; RFAs, PA Available.

October 14, 1994

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

May 22, 1998

Study Finds No Link Between Pill And Breast Cancer Risk

July 26, 2002